Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 USD | -0.86% | +2.67% | -43.04% |
05-14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.04% | 479M | |
+69.92% | 62.86B | |
-0.90% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.57% | 26.46B | |
-22.21% | 18.9B | |
+4.29% | 12.67B | |
+23.80% | 12.27B | |
+28.99% | 12.07B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Transcript : Editas Medicine, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 05